{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "POSTPOST", "regularMarketChangePercent": 2.0408204, "regularMarketPrice": 0.6, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.25, "epsForward": -0.4, "epsCurrentYear": -0.4, "priceEpsCurrentYear": -1.5, "sharesOutstanding": 50156700, "fiftyDayAverage": 0.64988, "fiftyDayAverageChange": -0.04987997, "fiftyDayAverageChangePercent": -0.07675258, "twoHundredDayAverage": 1.28784, "twoHundredDayAverageChange": -0.68784, "twoHundredDayAverageChangePercent": -0.5341036, "marketCap": 30094022, "forwardPE": -1.5, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.5 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "exchange": "PAR", "shortName": "NICOX S.A.", "longName": "Nicox S.A.", "messageBoardId": "finmb_131325", "exchangeTimezoneName": "Europe/Paris", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "fr_market", "esgPopulated": false, "firstTradeDateMilliseconds": 955522800000, "priceHint": 4, "regularMarketChange": 0.012000024, "regularMarketTime": 1683905703, "regularMarketDayHigh": 0.603, "regularMarketDayRange": "0.585 - 0.603", "regularMarketDayLow": 0.585, "regularMarketVolume": 101146, "regularMarketPreviousClose": 0.588, "fullExchangeName": "Paris", "financialCurrency": "EUR", "regularMarketOpen": 0.6, "averageDailyVolume3Month": 193721, "averageDailyVolume10Day": 105187, "fiftyTwoWeekLowChange": 0.048000038, "fiftyTwoWeekLowChangePercent": 0.08695659, "fiftyTwoWeekRange": "0.552 - 2.09", "fiftyTwoWeekHighChange": -1.4899999, "fiftyTwoWeekHighChangePercent": -0.71291864, "fiftyTwoWeekLow": 0.552, "fiftyTwoWeekHigh": 2.09, "earningsTimestamp": 1681882200, "earningsTimestampStart": 1689658200, "earningsTimestampEnd": 1690176600, "trailingAnnualDividendRate": 0.0, "symbol": "ALCOX.PA"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2405 Route Des Dolines Drakkar D", "city": "Valbonne", "zip": "06560", "country": "France", "phone": "33 4 97 24 53 00", "fax": "33 4 97 24 53 99", "website": "https://www.nicox.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Nicox S.A. operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating prostaglandin analog for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in phase 3 clinical trial. The company is also developing NCX 4251, a proprietary formulation of fluticasone for acute exacerbations of blepharitis that is in a Phase 2b clinical trial for the treatment of acute exacerbations of blepharitis; and NCX 1728.It offers VYZULTA, a latanoprostene bunod ophthalmic solution to treat patients with open-angle glaucoma or ocular hypertension; and ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis. The company was founded in 1996 and is headquartered in Valbonne, France.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Michele  Garufi Ph.D.", "age": 68, "title": "Co-Founder & Director", "yearBorn": 1954, "fiscalYear": 2021, "totalPay": {"raw": 475450, "fmt": "475.45k", "longFmt": "475,450"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andreas Rutger Segerros M.B.A., M.Sc.", "age": 62, "title": "Chief Exec. Officer", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Sandrine  Gestin", "age": 55, "title": "VP of Fin.", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Doug  Hubatsch", "age": 55, "title": "Exec. VP & Chief Scientific Officer", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Emmanuelle  Pierry", "age": 53, "title": "Gen. Counsel & Head of Legal Affairs", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Gavin M. Spencer", "age": 52, "title": "Exec. VP, Chief Bus. Officer & Head of Corp. Devel.", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ramesh  Krishnamoorthy", "title": "Sr. Director and Head of Late Stage CMC & Quality Control", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jose  Boyer", "title": "Consultant", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}